Published in Medical Letter on the CDC and FDA, November 14th, 2010
"Although adjuvant imatinib has proven effective in clinical trials, it is important to consider...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.